Page last updated: 2024-10-21

14,15-epoxy-5,8,11-eicosatrienoic acid and Kidney Diseases

14,15-epoxy-5,8,11-eicosatrienoic acid has been researched along with Kidney Diseases in 3 studies

14,15-epoxy-5,8,11-eicosatrienoic acid: RN given refers to cpd without isomeric designation

Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Imig, JD3
Jankiewicz, WK1
Khan, AH1
Campbell, WB1
Schmitz, JM1
Falck, JR1

Reviews

2 reviews available for 14,15-epoxy-5,8,11-eicosatrienoic acid and Kidney Diseases

ArticleYear
Orally Active Epoxyeicosatrienoic Acid Analogs.
    Journal of cardiovascular pharmacology, 2017, Volume: 70, Issue:4

    Topics: 8,11,14-Eicosatrienoic Acid; Administration, Oral; Animals; Blood Pressure; Cardiovascular Diseases;

2017
Epoxyeicosatrienoic acids, hypertension, and kidney injury.
    Hypertension (Dallas, Tex. : 1979), 2015, Volume: 65, Issue:3

    Topics: 8,11,14-Eicosatrienoic Acid; Animals; Antihypertensive Agents; Disease Models, Animal; Disease Progr

2015

Other Studies

1 other study available for 14,15-epoxy-5,8,11-eicosatrienoic acid and Kidney Diseases

ArticleYear
Epoxy Fatty Acids: From Salt Regulation to Kidney and Cardiovascular Therapeutics: 2019 Lewis K. Dahl Memorial Lecture.
    Hypertension (Dallas, Tex. : 1979), 2020, Volume: 76, Issue:1

    Topics: 8,11,14-Eicosatrienoic Acid; Animals; Arachidonic Acid; Cardiovascular Diseases; Cytochrome P-450 En

2020